CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-18 | HIGGINS JOHN L Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −10,000 | 40,335 | ||
| 2022-11-17 | HIGGINS JOHN L Chief Executive Officer | Sale | −10,000 | $78.32 | $783K | 416,731 |
| 2022-11-09 | Espinoza Octavio Chief Financial Officer | Sale | −1,696 | $75.64 | $128K | 8,857 |
| 2022-11-01 | Korenberg Matthew E President & COO | Grant or award | +27,714 | 86,021 | ||
| 2022-11-01 | Cochran Jennifer R. Former Director | Returned to the company | −1,004 | 1,161 | ||
| 2022-11-01 | Cochran Jennifer R. Former Director | Returned to the company · Employee Stock Option (right to buy) | −4,340 | 0 | ||
| 2022-11-01 | Patel Sunil Former Director | Returned to the company | −1,004 | 28,820 | ||
| 2022-11-01 | Patel Sunil Former Director | Returned to the company · Employee Stock Option (right to buy) | −4,340 | 0 | ||
| 2022-11-01 | Berkman Charles S Former Executive Officer | Returned to the company | −11,944 | 23,825 | ||
| 2022-11-01 | Berkman Charles S Former Executive Officer | Returned to the company · Employee Stock Option (right to buy) | −20,126 | 0 | ||
| 2022-11-01 | FOEHR MATTHEW W Former Executive Officer | Returned to the company | −20,304 | 162,187 | ||
| 2022-11-01 | FOEHR MATTHEW W Former Executive Officer | Returned to the company · Employee Stock Option (right to buy) | −34,214 | 0 | ||
| 2022-11-01 | Boyce Sarah Former Director | Returned to the company | −1,004 | 2,892 | ||
| 2022-11-01 | Boyce Sarah Former Director | Returned to the company · Employee Stock Option (right to buy) | −4,340 | 0 | ||
| 2022-11-01 | HIGGINS JOHN L Chief Executive Officer | Grant or award | +45,922 | 424,731 | ||
| 2022-09-16 | HIGGINS JOHN L Chief Executive Officer | Sale | −1,000 | $88.06 | $88K | 366,180 |
| 2022-09-16 | HIGGINS JOHN L Chief Executive Officer | Sale | −3,000 | $89.35 | $268K | 364,180 |
| 2022-09-15 | HIGGINS JOHN L Chief Executive Officer | Sale | −2,000 | $90.00 | $180K | 367,180 |
| 2022-06-30 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Other acquisition | +164 | $75.84 | $12K | 52,532 |
| 2022-06-30 | HIGGINS JOHN L Chief Executive Officer | Other acquisition | +164 | $75.84 | $12K | 369,180 |
Page 28 of 43 · 858 trades